| Date | Title | Description | Source |
| 10.01.2024 |
Nevro announces layoffs | Pain-treatment device company Nevro (NYSE:NVRO) announced that it is letting go of 63 employees, abo... | massdevice... |
| 16.08.2023 |
2-year data shows painful diabetic neuropathy relief with ... | Nevro (NYSE:NVRO) today announced 24-month data from its Senza painful diabetic neuropathy (PDN) spi... | massdevice... |
| 19.04.2023 | Nevro Names Kevin Thornal as New Chief Executive Officer and... | D. Keith Grossman to be Appointed as Executive Chairman
Company Announces Preliminary, Unaudited Wo... | einpresswi... |
| 07.03.2023 |
Nevro fully launches HFX iQ spinal cord stimulation | The HFX iQ SCS system. [Image courtesy of Nevro]Nevro (NYSE:NVRO) announced today that it initiated ... | massdevice... |
| 13.10.2022 |
FDA approves Nevro HFX iQ spinal cord stimulation | Senza HFX iQ spinal cord stimulation (SCS) system [Image from Nevro]Nevro (NYSE:NVR) announced that ... | massdevice... |
| 13.10.2022 | Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulat... | Next Generation Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to... | einpresswi... |
| 11.02.2022 | Nevro Announces Publication of 12-Month Data from SENZA-NSRB... | REDWOOD CITY, Calif., Feb. 11, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 25.01.2022 | Nevro to Report Fourth Quarter and Full-Year 2021 Financial ... | REDWOOD CITY, Calif., Jan. 24, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 10.01.2022 | Nevro Announces Preliminary, Unaudited Fourth Quarter and Fu... | REDWOOD CITY, Calif., Jan. 10, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 04.01.2022 | Nevro Announces UnitedHealthcare Coverage for High-Frequency... | REDWOOD CITY, Calif., Jan. 4, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device... | marketscre... |
| 22.12.2021 | Nevro Announces Settlement of IP Litigation with Nalu Medica... | REDWOOD CITY, Calif., Dec. 21, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 30.11.2021 | Nevro Announces Two Health Economic Poster Presentations at ... | REDWOOD CITY, Calif., Nov. 30, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 29.11.2021 | Nevro Announces Three Important Clinical Data Publications f... | REDWOOD CITY, Calif., Nov. 29, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 09.11.2021 | Nevro Reports Third Quarter 2021 Financial Results and Provi... | REDWOOD CITY, Calif., Nov. 8, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device... | marketscre... |
| 02.11.2021 | Nevro Announces Update in Patent Litigation with Boston Scie... | REDWOOD CITY, Calif., Nov. 1, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device... | marketscre... |
| 11.10.2021 | Nevro : to Report Third Quarter 2021 Financial Results | REDWOOD CITY, Calif., Oct. 11, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 31.08.2021 | Nevro : Announces Director Appointment | REDWOOD CITY, Calif., Aug. 31, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devic... | marketscre... |
| 31.08.2021 | Nevro Announces Director Appointment |
REDWOOD CITY, Calif., Aug. 31, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 19.07.2021 | Nevro Announces FDA Approval of its 10 kHz High Frequency Sp... |
REDWOOD CITY, Calif., July 19, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 07.07.2021 | Nevro : to Report Second Quarter 2021 Financial Results | REDWOOD CITY, Calif., July 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device... | marketscre... |
| 07.07.2021 | Nevro to Report Second Quarter 2021 Financial Results |
REDWOOD CITY, Calif., July 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devi... | prnewswire... |
| 22.06.2021 | Nevro Announces SENZA-PDN Clinical Data Presentation at the ... |
REDWOOD CITY, Calif., June 22, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 22.06.2021 | Nevro Announces SENZA-NSRBP Clinical Data Presentation at th... |
REDWOOD CITY, Calif., June 22, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 26.04.2021 | Nevro Introduces HFX, New Comprehensive Brand Identity Combi... |
REDWOOD CITY, Calif., April 26, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical de... | prnewswire... |
| 07.04.2021 | Nevro to Report First Quarter 2021 Financial Results |
REDWOOD CITY, Calif., April 7, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 05.04.2021 | Nevro Announces Publication Of Landmark SENZA-PDN Clinical T... |
REDWOOD CITY, Calif., April 5, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 27.01.2021 | Nevro to Report Fourth Quarter and Full-Year 2020 Financial ... |
REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 11.01.2021 | Nevro Announces Preliminary, Unaudited Fourth Quarter and Fu... |
REDWOOD CITY, Calif., Jan. 11, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 28.12.2020 | Nevro Announces FDA Submission for HF10® Therapy in Patients... |
REDWOOD CITY, Calif., Dec. 28, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 14.12.2020 | Nevro Announces Agreement to Conclude Its Patent Lawsuit in ... |
REDWOOD CITY, Calif., Dec. 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 03.12.2020 | Nevro Announces Director Appointment |
REDWOOD CITY, Calif., Dec. 3, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a... | prnewswire... |
| 17.11.2020 | Nevro Announces Abstract Presentations for PDN and NSRBP Tri... |
REDWOOD CITY, Calif., Nov. 17, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 05.11.2020 | Nevro Announces Third Quarter 2020 Financial Results |
REDWOOD CITY, Calif., Nov. 5, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical devi... | prnewswire... |
| 22.10.2020 | Nevro to Report Third Quarter 2020 Financial Results |
REDWOOD CITY, Calif., Oct. 22, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev... | prnewswire... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so... | vator.tv/n... |
| 18.04.2016 | Nevro gets FDA pre-market approval for spinal cord stimulati... | It is designed to alleviate pain. The electrical pulses are delivered by small electrodes on leads t... | medcitynew... |
| 14.04.2016 | Are IPOs worth the gamble? This investment panel’s answers m... | Here are some takeaways (unless in quotations, insights are not a direct quote):
When and why an en... | medcitynew... |
| 07.03.2013 | Nevro Raises $48M in Series C Financing | Nevro Corp., a Menlo Park, Calif.-based medical device company focused on improving pain relief, rai... | finsmes.co... |
| 07.03.2013 | Nevro Closes $48M Series C |
MENLO PARK, CA, Medical device company, focused on improving pain relief in patients suffering fro... | vcnewsdail... |
| 07.03.2013 | Funding: Nevro Corp. lands $48M in support of spinal cord st... | Menlo Park, Calif.-based Nevro Corp. raised $48 million in a Series C financing round in support of ... | massdevice... |
| 04.06.2012 | Boston Scientific lands FDA win for new stent lengths | Regu... | Boston Scientific lands FDA win for new stent sizes
Boston Scientific (NYSE:BSX) touted FDA clearanc... | massdevice... |
| 20.07.2011 | Nevro Raises $58M for Anti-Pain Device | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Menlo Park, CA-based Nevro, which ... | xconomy.co... |
| 19.07.2011 | Nevro Completes $58M Financing | Nevro Corp., a Menlo Park, California-based neuromodulation company focused on relief of chronic pai... | finsmes.co... |
| - | Nevro gets FDA pre-market approval for spinal cord stimulati... | Nevro Corp. has won pre-market approval from the Food and Drug Administration for its Senza spinal c... | medcitynew... |
| - | Are IPOs worth the gamble? This investment panel’s answers m... | At the MedCity INVEST conference this week, a panel made up of two CEOs who took their companies pub... | medcitynew... |
